Pyelonephritis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 60 pages | ID: P2CE3E19DCB3EN
VPAResearch

Abstracts

Pyelonephritis Drug pipeline report- 2020 is an annual R&D review of Pyelonephritis pipeline candidates. The report presents the current status of all major Pyelonephritis therapeutic compounds. Detailed insights into Pyelonephritis pipeline development, current status, companies, drug profiles and Pyelonephritis preclinical and clinical trials are included.

2020 Pyelonephritis Pipeline Market Insights
Pyelonephritis disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Pyelonephritis therapies, pipeline by phase and others are included.

Pyelonephritis pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Pyelonephritis Therapeutic Drug candidates
Both active and inactive Pyelonephritis pipeline drug candidates are included in the report

Pyelonephritis Clinical Trials and preclinical Studies
Pyelonephritis In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Pyelonephritis pipeline market developments
Pyelonephritis Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Pyelonephritis pipeline companies in active development
The report analyzes Pyelonephritis pipeline of the below companies-

Allecra Therapeutics GmbH, AstraZeneca Plc, Entasis Therapeutics Inc, Iterum Therapeutics Plc, Meiji Seika Pharma Co Ltd, Melinta Therapeutics Inc, Merck & Co Inc, MerLion Pharmaceuticals Pte Ltd, Nabriva Therapeutics Plc, Paratek Pharmaceuticals Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
10 Companies investing in Pyelonephritis pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Pyelonephritis pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. PYELONEPHRITIS PIPELINE MARKET INSIGHTS, 2020

1.1 Pyelonephritis Disease Overview
1.2 Pyelonephritis Drug Pipeline Snapshot, 2020
  1.2.1 Pyelonephritis Pipeline Drugs by Phase
  1.2.2 Pyelonephritis Pipeline Drugs by Company
  1.2.3 Pyelonephritis Pipeline Drugs by Mechanism of Action
  1.2.4 Pyelonephritis Pipeline Drugs by Route of Administration

2. PYELONEPHRITIS COMPANY WISE PIPELINE DETAILS

Allecra Therapeutics GmbH Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
AstraZeneca Plc Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Entasis Therapeutics Inc Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Iterum Therapeutics Plc Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Meiji Seika Pharma Co Ltd Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Melinta Therapeutics Inc Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Merck & Co Inc Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
MerLion Pharmaceuticals Pte Ltd Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Nabriva Therapeutics Plc Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Paratek Pharmaceuticals Inc Pyelonephritis Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. PYELONEPHRITIS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. PYELONEPHRITIS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts